Wellington Management Group’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Sell
92,241
-11,244
-11% -$384K ﹤0.01% 1527
2026
Q1
$3.42M Sell
103,485
-11,914
-10% -$504K ﹤0.01% 1457
2025
Q4
$5.34M Sell
115,399
-7,583
-6% -$317K ﹤0.01% 1400
2025
Q3
$4.3M Buy
122,982
+24,036
+24% +$836K ﹤0.01% 1475
2025
Q2
$2.93M Buy
98,946
+15,061
+18% +$430K ﹤0.01% 1491
2025
Q1
$2.5M Sell
83,885
-4,706
-5% -$144K ﹤0.01% 1511
2024
Q4
$2.54M Sell
88,591
-26,049
-23% -$862K ﹤0.01% 1521
2024
Q3
$4.43M Buy
114,640
+16,784
+17% +$599K ﹤0.01% 1365
2024
Q2
$3.15M Buy
97,856
+7,714
+9% +$267K ﹤0.01% 1419
2024
Q1
$3.5M Buy
+90,142
New +$3.15M ﹤0.01% 1411
2018
Q3
Sell
-38,226
Closed -$912K 2220
2018
Q2
$912K Buy
+38,226
New +$940K ﹤0.01% 1910
2016
Q2
Sell
-34,700
Closed -$629K 2101
2016
Q1
$629K Buy
+34,700
New +$631K ﹤0.01% 1913

Other funds holding COLL

Wellington Management Group's COLL Position: Q2 2026 in Review

Wellington Management Group reduced its Collegium Pharmaceutical (COLL) stake by 11% in Q2 2026, selling an estimated $384K and leaving 92,241 shares worth $3.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Wellington Management Group first reported a position in COLL in Q1 2016 and has held it in 12 quarters since. The position peaked at $5.34M in Q4 2025. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Wellington Management Group held 92,241 shares of Collegium Pharmaceutical worth $3.34M as of Q2 2026.
  • Wellington Management Group sold 11,244 Collegium Pharmaceutical shares in Q2 2026, an estimated $384K.
  • Collegium Pharmaceutical made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1527 holding.
  • Wellington Management Group first reported a position in Collegium Pharmaceutical in Q1 2016 and has held it in 12 quarters since.
  • Wellington Management Group's Collegium Pharmaceutical position peaked at $5.34M in Q4 2025.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.